Compositions and methods for treating gram positive...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A01K 67/027 (2006.01) A61K 31/202 (2006.01) A61K 39/40 (2006.01) C12Q 1/68 (2006.01) G01N 33/554 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2613453

Compositions and methods are provided for treating Gram positive bacterial infection in a mammalian subject. Compositions and methods are further provided for treating Gram positive bacterial skin infection in the mammalian subject. Compositions and methods are provided that comprise administering to the mammalian subject an effective amount of a compound that activates Scdl gene expression or activates Scdl gene product.

L'invention concerne des compositions et des méthodes de traitement d'une infection bactérienne à gram positif chez un mammifère. L'invention concerne également des compositions et des méthodes de traitement d'une infection bactérienne à gram positif cutanée chez ledit sujet. L'invention concerne des compositions et des méthodes consistant à administrer au sujet une quantité efficace d'un composé activant l'expression du gène Scdl ou activant le produit génique Scdl.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for treating gram positive... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating gram positive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating gram positive... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2075998

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.